Related Experiment Video
Updated: May 15, 2026
09:57
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a
Senthilkumar Durairaj1, Norene Keenan, Ann Hyslop
1Dundee Cancer Centre, Ninewells Hospital, Dundee, UK.
British Journal of Haematology
|January 9, 2013
Abstract
No abstract available in PubMed .